Enlivex Secures $212M to Launch RAIN Token Prediction Market Treasury

Enlivex Therapeutics Ltd., a Nasdaq-listed Israeli immunotherapy firm, has raised $212 million through a Private Investment in Public Equity (PIPE) deal. The funding will establish the world's first digital asset treasury for prediction markets using the RAIN token, marking a significant milestone in the convergence of traditional finance and blockchain innovation.

The transaction involves the sale of 212 million ordinary shares at $1.00 per share, representing an 11.5% premium over the stock's previous closing price. Former Italian Prime Minister Matteo Renzi will join the company's board upon deal closure, expected by November 25.

While primarily focused on advancing its Allocetra™ treatment for knee osteoarthritis, Enlivex's foray into digital assets signals growing institutional interest in tokenized financial instruments. The treasury will be funded through a mix of USD and USDT, bridging conventional and crypto-native capital.